# A Multiple Dose Study Of PF-04620110 In Type 2 Diabetes Patients

> **NCT01298518** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 48 (actual)

## Conditions studied

- Type 2 Diabetes Patients

## Interventions

- **DRUG:** PF-04620110
- **DRUG:** PF-04620110
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01298518
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** 2011-05
- **Final completion:** 2011-05
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2012-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01298518

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01298518, "A Multiple Dose Study Of PF-04620110 In Type 2 Diabetes Patients". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01298518. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*